| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $203.8M | +6.2% | +62.0% |
| Cost of Revenue | $155.1M | +12.5% | +73.5% |
| Gross Profit | $48.7M | -9.9% | +33.7% |
| R&D Expense | $4.8M | +3.8% | +3.0% |
| SG&A Expense | $15.3M | -8.5% | +39.2% |
| Operating Income | $28.4M | -12.7% | +38.7% |
| Pre-tax Income | $26.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $49.0M | -0.8% | +21.2% |
| Accounts Receivable | $88.0M | +7.2% | +13.5% |
| Inventory | $152.2M | +2.2% | +45.1% |
| Current Assets | $318.9M | +2.8% | +20.3% |
| Total Assets | $458.9M | +4.9% | +35.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.7M | — | — |
| Capital Expenditures | $7.0M | — | — |
| Investing Cash Flow | -$7.0M | — | — |
| Financing Cash Flow | -$27.5M | — | — |
| Free Cash Flow | $21.8M | — | — |
| -14.0% |
| +51.8% |
| Income Tax | -$876K | +95.6% | -416.2% |
| Net Income | $27.6M | -46.1% | +59.3% |
| EPS (Basic) | $1.20 | -46.2% | +60.0% |
| EPS (Diluted) | $1.20 | -45.9% | +60.0% |
| $139.6M |
| -43.5% |
| -46.2% |
| Long-term Debt | $15K | -21.1% | -70.6% |
| Total Liabilities | $296.5M | -1.8% | -0.2% |
| Stockholders' Equity | $162.5M | +19.8% | +285.8% |